Many children in the USA are prescribed psychotropic drugs that have not been fully investigated in paediatric clinical trials. The common practice of prescribing psychotropic drugs off-label poses unknown and potentially serious short- and long-term consequences for these children. This paper briefly reviews the factors associated with the lack of paediatric clinical trials. We advocate a shift toward increasing paediatric trials with psychotropic drugs through a combination of adequate safety controls, additional reimbursement/compensation, a more organised and large-scale effort to collate results and outcomes across researchers and studies and additional public education about the importance of this research. In addition, we encourage the re-examination of the ethical standards for children's participation in phase 1 clinical trials as well as argue for longitudinal developmental studies on children who are prescribed off-label psychotropic drugs.
- Behavioural research
- philosophical ethics
- suicide/assisted suicide
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding This work was supported, in part, by funds designated to the Ohio State University Hospitals East projects.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Prerequisites to support high-quality clinical trials in children and young people
- Challenges in clinical trials for children and young people
- Informed consent and assent guide for paediatric clinical trials in Europe
- Non-static framework for understanding adaptive designs: an ethical justification in paediatric trials
- StaR Child Health: developing evidence-based guidance for the design, conduct and reporting of paediatric trials
- A systematic review of paediatric randomised controlled drug trials published in 2007
- Informed consent for paediatric clinical trials in Europe
- Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee
- PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it
- Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary